To advocate for the wider adoption of in vitro diagnostics (IVDs) to support the UK NHS's 10-Year Health Plan, as stated in the report by the Royal College of Pathologists.
Approach:
Report Overview: The report titled 'Making Every Test Count' examines how diagnostic testing can align with NHS strategic priorities.
Impact of Diagnostics: The report highlights that IVDs influence around 70% of clinical decisions while constituting less than 1% of NHS spending.
Real-World Examples: The report presents examples of community-based testing and self-sampling initiatives that improve patient care.
Digital Pathology: The report discusses the role of AI in managing laboratory workloads and improving diagnostic processes.
Recommendations: The report outlines actions for NHS governing bodies to enhance diagnostic testing and digital pathology.
Key Findings:
Inconsistent adoption and fragmented procurement hinder patient access to IVDs, as noted in the report.
Community testing reduced turnaround times significantly and improved treatment decisions, according to the report.
Self-sampling for HPV could enhance cervical cancer screening participation, as highlighted in the report.
AI-enabled digital pathology can optimize laboratory efficiency but requires infrastructure investment, as stated in the report.
Interpretation:
The report emphasizes the critical role of diagnostics in healthcare and the need for systemic changes.
Limitations:
Current workforce shortages and limited digital interoperability impede progress, as mentioned in the report.
The report does not provide specific data on the cost-effectiveness of proposed changes.
Conclusion:
The report states that urgent action from the government is necessary to optimize the use of IVDs for patient benefit.
An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.
